Myopodin isoforms alter the chemokinetic response of PC3 cells in response to different migration stimuli via differential effects on Rho-ROCK signaling pathways

Carcinogenesis

Volumn 33, Issue 11, 2012, Pages 2100-2107

  Kai, FuiBoon ^a   Tanner, Kaitlyn ^a   King, Caroline ^a   Duncan, Roy ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; ACTIN BINDING PROTEIN; BIOLOGICAL MARKER; CHEMOATTRACTANT; ISOPROTEIN; MYOPODIN; PROTEIN SERINE THREONINE KINASE; PUROMYCIN; RHO FACTOR; RHO KINASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL; CANCER INVASION; CELL ASSAY; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CELL STRAIN; CELL STRAIN PC3; CELL STRUCTURE; CHEMOKINESIS; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; PDZ DOMAIN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROCESSING; RHO ROCK SIGNALING PATHWAY; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TERMINAL SEQUENCE; TUMOR MICROENVIRONMENT;

ANIMALS; BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES; CLONING, MOLECULAR; HUMANS; IMMUNOPRECIPITATION; MALE; MICE; MICROFILAMENT PROTEINS; MYOSIN HEAVY CHAINS; MYOSIN TYPE I; MYOSIN TYPE III; NIH 3T3 CELLS; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 84868618705     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs268     Document Type: Article

References (33)

1. Bill-Axelson, A. et al. (2008) Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J. Natl. Cancer Inst., 100, 1144-1154.
2. Lin, F. et al. (2001) Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers. Am. J. Pathol., 159, 1603-1612.
3. Yu, Y.P. et al. (2006) Inactivation of myopodin expression associated with prostate cancer relapse. Urology, 68, 578-582.
4. Sanchez-Carbayo, M. et al. (2003) Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome. Oncogene, 22, 5298-5305.
5. Esteban, S. et al. (2012) Diagnostic and prognostic utility of methylation and protein expression patterns of myopodin in colon cancer. Tumour Biol., 33, 337-346.
6. Jing, L. et al. (2004) Expression of myopodin induces suppression of tumor growth and metastasis. Am. J. Pathol., 164, 1799-1806.
7. Yu, Y.P. et al. (2006) Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin. Cancer Res., 66, 7414-7419.
8. Yu, Y.P. et al. (2011) Phosphorylation and interaction of myopodin by integrin-link kinase lead to suppression of cell growth and motility in prostate cancer cells. Oncogene, 30, 4855-4863.
9. De Ganck, A. et al. (2009) Down-regulation of myopodin expression reduces invasion and motility of PC-3 prostate cancer cells. Int. J. Oncol., 34, 1403-1409.
10. Van Impe, K. et al. (2003) The nucleo-cytoplasmic actin-binding protein CapG lacks a nuclear export sequence present in structurally related proteins. J. Biol. Chem., 278, 17945-17952.
11. De Ganck, A. et al. (2008) Multiple isoforms of the tumor suppressor myopodin are simultaneously transcribed in cancer cells. Biochem. Biophys. Res. Commun., 370, 269-273.
12. Schroeter, M. et al. (2004) Ca2+-calmodulin regulates fesselin-induced actin polymerization. Biochemistry, 43, 13875-13882.
13. Leinweber, B.D. et al. (1999) Fesselin: a novel synaptopodin-like actin binding protein from muscle tissue. J. Muscle Res. Cell. Motil., 20, 539-545.
14. Schroeter, M.M. et al. (2008) The actin binding protein, fesselin, is a member of the synaptopodin family. Biochem. Biophys. Res. Commun., 371, 582-586.
15. Weins, A. et al. (2001) Differentiation- and stress-dependent nuclear cytoplasmic redistribution of myopodin, a novel actin-bundling protein. J. Cell Biol., 155, 393-404.
16. Linnemann, A. et al. (2010) The sarcomeric Z-disc component myopodin is a multiadapter protein that interacts with filamin and alpha-actinin. Eur. J. Cell Biol., 89, 681-692.
17. Davies, S.P. et al. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J., 351(Pt 1), 95-105.
18. Yamazaki, D. et al. (2005) Regulation of cancer cell motility through actin reorganization. Cancer Sci., 96, 379-386.
19. Parsons, J.T. et al. (2010) Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol., 11, 633-643.
20. Amano, M. et al. (2010) Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken), 67, 545-554.
21. Qin, J. et al. (2009) Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis. Oncogene, 28, 1853-1863.
22. Gao, Y. et al. (2004) Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. U.S.A., 101, 7618-7623.
23. Entschladen, F. et al. (2005) Analysis methods of human cell migration. Exp. Cell Res., 307, 418-426.
24. Yao, H. et al. (2006) RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility. Oncogene, 25, 2285-2296.
25. Sequeira, L. et al. (2008) Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clin. Exp. Metastasis, 25, 569-579.
26. Somlyo, A.V. et al. (2000) Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem. Biophys. Res. Commun., 269, 652-659.
27. Angelucci, A. et al. (2002) Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators. Biol. Chem., 383, 229-234.
28. Hu, S. et al. (2010) Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion. Mol. Cancer, 9, 30.
29. Kumano, M. et al. (2008) Enhanced progression of human prostate cancer PC3 cells induced by the microenvironment of the seminal vesicle. Br. J. Cancer, 98, 356-362.
30. Pankov, R. et al. (2005) A Rac switch regulates random versus directionally persistent cell migration. J. Cell Biol., 170, 793-802.
31. Pham, M. et al. (2006) Smooth muscle alpha-actinin binds tightly to fesselin and attenuates its activity toward actin polymerization. J. Muscle Res. Cell. Motil., 27, 45-51.
32. Schroeter, M.M. et al. (2008) In vitro characterization of native mammalian smooth-muscle protein synaptopodin 2. Biosci. Rep., 28, 195-203.
33. Etienne-Manneville, S. (2008) Polarity proteins in migration and invasion. Oncogene, 27, 6970-6980.